MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
ENDRA Life Sciences Operating Cash Flow 2011-2026 | NDRA
Annual Operating Cash Flow ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.18 M | -7.4 M | -9.55 M | -12.8 M | -11.1 M | -10.7 M | -8.59 M | -7.7 M | -3.3 M | -1.32 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.32 M | -12.8 M | -7.77 M |
Quarterly Operating Cash Flow ENDRA Life Sciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.12 M | - | - | -1.29 M | - | - | - | -2.14 M | - | - | - | -2.51 M | - | -9.68 M | -6.43 M | -3.1 M | - | -8.47 M | -5.72 M | -2.92 M | - | -8.67 M | -6.54 M | -3.09 M | - | -6.68 M | -4.2 M | -2.54 M | - | -5.8 M | -4.33 M | -2.45 M | - | -1.93 M | -1.38 M | -236 K | - | -769 K | -769 K | -53.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -53.8 K | -9.68 M | -3.71 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 19.72 | 2.71 % | $ 572 M |  USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 16.36 | 2.57 % | $ 495 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 114.94 | 1.22 % | $ 9.48 B |  Irlanda |
 |
Agilent Technologies
A
|
1.48 B | $ 113.33 | 2.5 % | $ 34.5 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Celcuity
CELC
|
-153 M | $ 138.86 | 6.03 % | $ 6.49 B | USA |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 2.31 | 17.26 % | $ 3.07 M | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Illumina
ILMN
|
837 M | $ 141.35 | -0.24 % | $ 22.5 B | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 113.24 | 15.33 % | $ 14.2 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 21.1 | 2.78 % | $ 1.12 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 96.33 | 3.7 % | $ 6.5 B | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 421.05 | 0.27 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 082.63 | 3.03 % | $ 22.3 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
26.4 M | $ 19.2 | 2.4 % | $ 430 M | USA |
 |
Natera
NTRA
|
-432 M | $ 202.96 | 3.53 % | $ 20 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 156.38 | 2.59 % | $ 7.75 B | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 7.86 | 11.58 % | $ 701 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.79 | 4.77 % | $ 1.13 B | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 3.74 | 5.21 % | $ 346 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 449.72 | 0.43 % | $ 170 B | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 5.69 | 2.62 % | $ 237 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 54.25 | 9.6 % | $ 3.24 B | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.35 | -1.26 % | $ 5.4 M | USA |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.6 | 6.65 % | $ 216 M | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 257.11 | 1.35 % | $ 21.4 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
653 M | $ 341.81 | 2.57 % | $ 20.4 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.73 | 4.49 % | $ 1.89 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 193.73 | 1.75 % | $ 21.5 B | USA |